Doctors Without Borders (MSF) has called for a drastic reduction in the price of a key medication used to prevent HIV ...
Doctors Without Borders has called for a drastic reduction in the price of lenacapavir, a key medication used to prevent HIV ...
Local production would strengthen healthcare security across the continent and reduce reliance on imported medicines.
Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started ...
Following in the footsteps of Gilead Sciences, Merck & Co. has signed voluntary licensing agreements to enable access to its ...
Three sub-Saharan African drugmakers will produce an HIV prevention pill under licensing agreements with the pharma giant.
Doctors Without Borders is calling for a drastically lower price for the drug lenacapavir, which is used to prevent HIV ...
Since the start of the HIV epidemic in 1981, over 700,000 Americans have lost their lives to AIDS. Being infected used to be a death sentence. But now, 40 years later, the U.S. is on the precipice of ...
Three companies from sub-Saharan Africa, including Aspen Pharmacare Holdings ( APNHF) ( APNHY ), and four from India, ...
The US Food and Drug Administration's (FDA) drug regulatory division announced the approval of a new indication for Gilead's Truvada (emtricitabine/tenofovir disoproxil fumarate), making it the first ...
California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state, researchers announced Tuesday. The pill, which is already used to treat HIV patients, will be ...
Aspen Pharmacare Holdings Ltd. secured the rights to develop, manufacture and sell potentially the world’s first monthly oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results